2023 HRS expert consensus statement on the management of arrhythmias during pregnancy.
Antiarrhythmic
Atrial fibrillation
Bradyarrhythmia
Fetal arrhythmia
Inherited arrhythmia syndrome
Maternal arrhythmia
Pregnancy
Supraventricular tachycardia
Tachyarrhythmia
Ventricular tachycardia
Journal
Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
12
05
2023
accepted:
12
05
2023
medline:
23
10
2023
pubmed:
22
5
2023
entrez:
21
5
2023
Statut:
ppublish
Résumé
This international multidisciplinary expert consensus statement is intended to provide comprehensive guidance that can be referenced at the point of care to cardiac electrophysiologists, cardiologists, and other health care professionals, on the management of cardiac arrhythmias in pregnant patients and in fetuses. This document covers general concepts related to arrhythmias, including both brady- and tachyarrhythmias, in both the patient and the fetus during pregnancy. Recommendations are provided for optimal approaches to diagnosis and evaluation of arrhythmias; selection of invasive and noninvasive options for treatment of arrhythmias; and disease- and patient-specific considerations when risk stratifying, diagnosing, and treating arrhythmias in pregnant patients and fetuses. Gaps in knowledge and new directions for future research are also identified.
Identifiants
pubmed: 37211147
pii: S1547-5271(23)02246-4
doi: 10.1016/j.hrthm.2023.05.017
pii:
doi:
Substances chimiques
Anti-Arrhythmia Agents
0
Types de publication
Practice Guideline
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e175-e264Informations de copyright
Copyright © 2023 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.